For ProvidersProvider ResourcesProvider News

APPROVAL OF THE NOVAVAX COVID 19 VACCINE

Effective October 3, 2023, the Federal Drug Administration (FDA) announced the approval of the updated 2023–2024 monovalent XBB.1.5 variant Novavax COVID-19 Vaccine, Adjuvanted.

Learn More

Read
More

Medicaid Update – Medicaid Coverage of Point of Care Syphilis Testing

TO: All Primary Care Providers Effective immediately, MetroPlusHealth will cover Point of Care (POC) Syphilis Testing to ensure equitable access and screening to help…

Medicaid Update – New York State Medicaid Coverage of Therapeutic Transcranial Magnetic Stimulation

TO: Behavioral Health Providers Effective November 1, 2025, Therapeutic Transcranial Magnetic Stimulation (TMS) is a covered benefit under Current Procedural Terminology…

Announcing our new Utilization Management (UM) Software System

TO: All MetroPlusHealth Providers MetroPlusHealth is excited to announce we are transitioning to a new internal Utilization Management (UM) software…

Medicaid Drug Rebate Program – Billing Guidance for Practitioner-Administered Drugs

TO: All Providers Dear Valued MetroPlusHealth Provider, MetroPlusHealth is committed to keeping our provider network informed of important Department of…
last updated: March 13, 2024
MetroPlusHealth
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.